Agios Pharmaceuticals, Inc. · NASDAQ:AGIO
Agios Pharmaceuticals, Inc. shareholders
As of Sep 30, 2026, 236 institutions reported holding Agios Pharmaceuticals, Inc. Largest: BlackRock, Vanguard and Farallon Capital Management, L.L.C. New holders, exits, insiders and big stakes, each with its filing.
| Holder | Shares | % of Agios Pharmaceuticals, Inc. | Change | Filed |
|---|---|---|---|---|
| BlackRock | 6.23M | −227K | Nov 13, 2026 | |
| Vanguard | 6.03M | −32,645 | Nov 13, 2026 | |
| Farallon Capital Management, L.L.C. | 5.94M | +22,000 | Nov 16, 2026 | |
| D. E. Shaw & Co., Inc. | 3.89M | +782K | Nov 16, 2026 | |
| Morgan Stanley | 3.44M | +2.47M | Nov 13, 2026 | |
| State Street | 3.26M | −269K | Nov 12, 2026 | |
| Armistice Capital, LLC | 2.58M | +178K | Nov 16, 2026 | |
| Nomura | 1.96M | −152K | Nov 16, 2026 | |
| Assenagon Asset Management S.A. | 1.89M | +1.68M | Oct 15, 2026 | |
| Erste Asset Management GmbH | 1.8M | −350K | Nov 12, 2026 |